University of British Columbia

Category

NYU Langone Among First to Treat COVID-19 Patients with Novel Antibody Arising out of UBC Spinoff Platform & Rapid Lilly Drug Development

NYU Grossman School of Medicine recently began treating patients in a clinical trial to determine whether an antibody therapy known as LY-CoV555 can safely reduce COVID-19 severity. Sponsored by Eli Lilly and Company, this experimental treatment consists of...

B.C. Research Focuses on Managing Immune Response in Critically ill COVID-19 Patients

British Columbia (B.C.) physicians and scientists are learning more about the links between the body’s immune system and the new coronavirus after the recovery of a 32-year-old who nearly died from acute COVID-19. Physicians and researchers at Vancouver General...

UBC & Vancouver General Hospital Lead AWS-Powered AI Initiative for Superior COVID-19 Diagnosis

An artificial intelligence study led by Vancouver clinical physicians and researchers gains momentum as they combine thousands of chest images of COVID-19 patients from around the world. By collecting thousands of CT scans and X-rays from all corners of the globe...

Pin It on Pinterest